ArticleCancer immunology research2015

Checkpoint blockade immunotherapy relies on T-bet but not Eomes to induce effector function in tumor-infiltrating CD8+ T cells.

Melissa M Berrien-Elliott et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.